At Xyla, we deliver high-quality, patient-centred screening services designed to identify serious health conditions at their earliest and most treatable stages. Our nurse-led, technology-enabled approach ensures that every individual receives compassionate care in a way that’s accessible, inclusive and tailored to their needs.
We specialise in reaching underserved groups, including:
Lung cancer screening is essential for detecting cancer early, when treatment is most effective. By bringing diagnostics closer to patients, we improve access to these vital screening services.
Integrating workforce, technology, and clinical governance we deliver a safe, high-quality Lung Cancer Screening experience.
We provide trained nursing and administrative staff to support:
Alongside Lung Cancer Screening, we also provide screening in the following areas:
Our approach aligns with your governance standards, helping to:
As a CQC-registered provider, we meet the required standards for quality and safety in healthcare delivery.
Aligning with your governance standards to improving patient experience, boosting productivity, and ensuring safety.
Over 60% of referrals from GPs complete a lung cancer screening
DNS rate of below 7%
97% patient satisfaction
30% increase in patient contact rates
Find out more about our recent Lung Cancer Screening programme for South Yorkshire and Bassetlaw Cancer Alliance.
Fields marked with an * are required.
Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)